跳至主要内容
临床试验/NCT01724658
NCT01724658已完成2 期

Effectiveness of Testosterone Undecanoate to Improve Sexual Function in Postmenopausal Women

Chulalongkorn University1 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2012年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
70
试验地点
1
主要终点
female sexual function index score

研究概览

简要总结

Additional testosterone undecanoate can improve female sexual function in postmenopausal women which one aspects of quality of life. The dose adjustment can reduce incidence of adverse effects and low cost of treatment with effective outcome.

详细描述

Research Question:

" Does oral testosterone undecanoate improve sexual problem in postmenopausal women? " Type Research:Clinical research

Study design:

Randomized double-blinded placebo controlled trial

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
40 Years 至 60 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • postmenopausal women with age between 40-60 years
  • Women complain about her sexual problem and her score of Female Sexual Function Index ≤ 26.5

排除标准

  • women with previous use of hormonal replacement or anti-psychiatric drugs within 3 months
  • women with history of or present premalignancies/malignancies
  • women present with liver disease or abnormal liver enzyme
  • women with active cardiovascular, cerebrovascular or thromboembolic disorders
  • women with Present psychiatric disease
  • Partner have sexual dysfunction

研究组 & 干预措施

Testosterone undecanoate

Experimental

testosterone undecanoate 40 mg orally twice a week plus progynova 1mg oral daily

干预措施: Testosterone undecanoate (Drug)

placebo

Placebo Comparator

placebo twice a week with progynova 1 mg oral daily

干预措施: placebo (Drug)

结局指标

主要结局

female sexual function index score

时间窗: 8 weeks

次要结局

  • adverse effects of the drug(8 week)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验